Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study

Use and outcomes in men with metastatic castration-sensitive prostate cancer (mCSPC) treated with docetaxel in addition to androgen deprivation therapy (ADT): Analysis of real-world data in the United States (US).

(2020) Neeraj Agarwal et al.   JOURNAL OF CLINICAL ONCOLOGY

Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2020) C. Parker et al.   ANNALS OF ONCOLOGY

611O Abiraterone acetate plus prednisolone for hormone-naïve prostate cancer (PCa): Long-term results from metastatic (M1) patients in the STAMPEDE randomised trial (NCT00268476)

(2020) N. James et al.   ANNALS OF ONCOLOGY

Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I

(2020) William T. Lowrance et al.   JOURNAL OF UROLOGY

Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial

(2019) Karim Fizazi et al.   LANCET ONCOLOGY

ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer

(2019) Andrew J. Armstrong et al.   JOURNAL OF CLINICAL ONCOLOGY

Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer

(2019) Ian D. Davis et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer

(2019) Kim N. Chi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Health-related quality of life after apalutamide treatment in patients with metastatic castration-sensitive prostate cancer (TITAN): a randomised, placebo-controlled, phase 3 study

(2019) Neeraj Agarwal et al.   LANCET ONCOLOGY

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial

(2018) Christos E. Kyriakopoulos et al.   JOURNAL OF CLINICAL ONCOLOGY

Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group

(2008) Howard I. Scher et al.   JOURNAL OF CLINICAL ONCOLOGY